C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced its partner Betta Pharmaceuticals ...
But in 2018 their plans suddenly changed. They were on a real estate agent’s website to check out a friend’s home for sale when another listing, for a “unique” home built circa 1920, caught their eye.
BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst ...